Overall Technical outlook

Price Summary

On 2025-08-13, Mankind Pharma Limited's shares started at 2442.7, peaked at 2483.8, bottomed out at 2436.9, and ended 0.95% higher at 2466.0, with 376033 shares traded.
The stock's highest value over the last 52 weeks is 2998.4, and the lowest value is 2161.7.
The anticipated price is forecasted to be between 2150.0 and 3300.0, with an average price expectation of 2794.2942, based on input from 17 analysts.

Technicals

Support and Resistance: The current price of 2466.0 is supported at 2452.15, with resistance at 2564.2. This suggests that the price for MANKIND might remain between these levels, where 2452.15 acts as a floor and 2564.2 as a ceiling in the market.
MANKIND supportResistance b34b63
Support/Resistance for MANKIND


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
MANKIND aroon b34b63
Aroon chart for Mankind Pharma Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
MANKIND bbands b34b63
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR continues its bearish trend for Mankind Pharma Limited, setting a resistance level that could hinder upward momentum. This resistance suggests that the market may face challenges in breaking higher, reflecting persistent bearish sentiment.
MANKIND psar b34b63
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The stochastic indicator reflects a bullish signal as the K-line crosses above the D-line and remains below 20. This setup is typically viewed as the beginning of a bullish move, suggesting that the market might soon experience upward momentum. Traders could see this as an opportunity to enter at a favorable point.
MANKIND stoch b34b63
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance for MANKIND, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
MANKIND trippleSMA b34b63
Tripple SMA chart for Mankind Pharma Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.